ISCT 2026

Join us at the International Society for Cell & Gene Therapy (ISCT) and discover how we are helping advance smarter biomarker discovery, faster assay development, and standardization across sites for cell therapy research.

Visit our booth to explore cell therapy solutions, including:
 

• BD FACSDiscover™ A8 Cell Analyzer with BD SpectralFX™ and BD CellView™ Image Technology
  
  
• BD FACSLyric™ System with an automated solution for scalable, standardized workflows
  
  
• Single-cell multiomics tools & assays to deepen insight from early discovery through translational research

Whether you’re advancing discovery, optimizing assays, or scaling across sites, stop by to see how Waters Biosciences, formerly BD Biosciences can support your cell therapy pipeline—from insight to impact. 

From Insight to Impact: Advancing Flow Cytometry and Streamlining Cell Therapy Workflows

When: Thursday, May 7 from 12:30-13:30

Where: Wicklow Hall 1

Speakers:

Lilja Hardardottir, PhD 
Senior Scientist, AstraZeneca 

Gianluca Rotta, PhD 
Scientific Affairs Manager, BD Biosciences

Breakthrough cell therapies require analytical platforms capable of resolving cellular complexity with greater depth, speed, and precision. While traditional flow cytometry has been a cornerstone technology for decades, advancing cell therapy development now demands multidimensional insights that extend beyond conventional fluorescence-based parameters. 
 

This session will highlight how the integration of real-time imaging with spectral flow cytometry is expanding the analytical capabilities available to researchers. By uniting real-time imaging with advanced spectral detection, this approach enables more accurate discrimination of rare, heterogeneous, or phenotypically subtle cell subsets. The enhanced resolution and contextual information support more rigorous characterization, streamline experimental workflows, and ultimately facilitate a deeper understanding of cell behavior. 
 

As a leader in next generation cell analysis technologies, Waters Biosciences provides an integrated portfolio designed to support the full cell therapy continuum—from early discovery and process optimization to manufacturing and quality control. Attendees will learn how these advanced analytical capabilities can help reduce development bottlenecks, improve process consistency, and accelerate the path toward delivering high quality, transformative cell therapies with greater clarity and confidence.

Resources

• Learn more about our CAR‑T and cell therapy solutions

• Learn more about immuno-therapy solutions